Find uplifting stories about heroes, innovations, and solutions
18 results for "biotech innovation"
A new partnership between Switzerland and Brazil is offering funding and mentorship to startups creating sustainable solutions for the Amazon rainforest. The program connects European innovation with local knowledge to tackle climate change while boosting the region's economy.
A new partnership between Canadian and Japanese biotech companies could slash the cost of life-saving gene therapies by making them easier to produce. The collaboration aims to help more patients access treatments that were once financially out of reach.
An Australian startup has created the world's first system that runs computer code on living human neurons, combining biology with silicon chips. The shoebox-sized device could make computing more energy-efficient while opening new doors for disease research.
A New York company is building virtual copies of human bodies to solve medicine's biggest data problem. These physics-based digital twins could revolutionize how we test treatments and predict injuries.
China's rapidly growing biotech sector is transforming how new medicines reach patients worldwide. The expansion signals more resources, faster innovation, and greater competition in the race to cure diseases.
Families dealing with Hunter syndrome just gained a powerful new treatment option after the FDA granted accelerated approval to Denali Therapeutics' groundbreaking drug. The decision marks a turning point for rare disease patients after a year of tougher regulatory outcomes.
A New York startup is genetically engineering chickens to produce lifesaving medications in their eggs, potentially cutting drug costs to one-tenth their current price. After decades of struggle, new breakthroughs are finally making egg-based medicine production practical.
Breakout Ventures just raised $114 million to fund startups using AI to solve problems in biology, chemistry, and materials science. The investment signals growing confidence that AI's biggest breakthroughs will come from laboratories, not social apps.
A Cambridge biotech just secured $5 million to fast-track a groundbreaking Alzheimer's treatment that targets brain inflammation instead of protein buildup. The therapy could help millions by addressing a root cause that's been overlooked for decades.
A wireless eye implant that restored central vision to people with late-stage macular degeneration just secured $230 million to bring the technology to Americans. The device pairs high-tech glasses with a retinal implant to help people see again after 12 months of use.
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
A two-year MIT program has helped 21 professors transform their lab discoveries into 16 biotech startups that have raised over $70 million. With a new $3 million gift, the initiative aims to launch 40 life-saving companies by 2029.
A new biotech company just secured $175 million to develop a promising Alzheimer's treatment that could help millions of families. Korsana Biosciences is joining the fight against dementia with a fresh approach to clearing harmful brain plaques.
A powerful group of European venture capital firms just launched a coalition to unlock more funding for life sciences startups across the continent. The move tackles one of Europe's biggest challenges in biotech innovation.
Biotech company Evommune just reported positive results from a mid-stage clinical trial for a new eczema treatment. The news offers fresh hope for millions living with the chronic skin condition.
A mathematician-led team is using artificial intelligence to decode the human immune system, already helping pharmaceutical giants predict which patients will benefit most from life-saving treatments. Their database of 40,000 patient samples doubles yearly and could revolutionize how we treat cancer and autoimmune diseases.
A biotech company is launching with a groundbreaking mission: using GLP-1 medications to treat substance use disorders instead of weight loss. Baseline Therapeutics could open new hope for millions struggling with addiction.
The world's first drug that could actually slow osteoarthritis instead of just masking pain is finally within reach. Three South Korean biotech companies are racing to bring breakthrough treatments to millions suffering from the painful joint disease.